11-K 1 form11kmarch08.htm FORM 11K 3/08


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 11-K

ANNUAL REPORT

PURSUANT TO SECTION 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

(Mark One)

(X)

ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED].

For the fiscal year ended March 31, 2008

OR

()

TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED].

For the transition period from ____ to ____.

 

Commission File No. 0-23832

A. Full title of the plan and address of the plan, if different from that of the issuer named below:

PSS WORLD MEDICAL, INC. SAVINGS PLAN

B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

PSS WORLD MEDICAL, INC.

4345 Southpoint Boulevard

Jacksonville, Florida 32216

REQUIRED INFORMATION

 

The PSS World Medical, Inc. Savings Plan (the “Plan”) is subject to the requirements of the Employee Retirement Income Security Act of 1974 (“ERISA”). The following financial statements and schedules of the Plan have been prepared in accordance with the financial reporting requirements of ERISA.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN

 

March 31, 2008 and 2007

Table of Contents

 

 

 

 

 

Page

 

 

Report of Independent Registered Public Accounting Firm

 4

 

 

Financial Statements:

 

 

 

Statements of Net Assets Available for Benefits

 5

Statement of Changes in Net Assets Available for Benefits

 6

 

 

Notes to Financial Statements

7-12

 

 

Supplemental Schedule*

 

 

 

Schedule H, Line 4a Schedule of Delinquent Participant Contributions

    13

Schedule H, Line 4i-Schedule of Assets (Held at End of Year)

14-15

 

 

 

 

 

 

* Other schedules required by 29 CFR 2520.103–10 of the Department of Labor’s Rules and Regulations for Reporting and Disclosure under ERISA have been omitted because they are not applicable, or are not required for participant–directed investment transactions.

 

 

 

3

 

Report of Independent Registered Public Accounting Firm

To the Participants and Administrator of the

PSS World Medical, Inc. Savings Plan:

We have audited the accompanying statements of net assets available for benefits of PSS World Medical, Inc. Savings Plan as of March 31, 2008 and 2007, and the related statement of changes in net assets available for benefits for the year ended March 31, 2008. These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of PSS World Medical, Inc. Savings Plan as of March 31, 2008 and 2007, and the changes in net assets available for benefits for the year ended March 31, 2008, in conformity with U.S. generally accepted accounting principles.

 

Our audits were performed for the purpose of forming an opinion on the basic financial statements taken as a whole. The supplemental schedules: Schedule H, Line 4a- Schedule of Delinquent Participant Contributions and Schedule H, Line 4i-Schedule of Assets (Held at End of Year) as of March 31, 2008, are presented for the purpose of additional analysis and are not a required part of the basic financial statements but are supplementary information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. These supplemental schedules are the responsibility of the Plan’s management. These supplemental schedules have been subjected to the auditing procedures applied in the audits of the basic financial statements and, in our opinion, are fairly stated in all material respects in relation to the basic financial statements taken as a whole.

 

September 18, 2008

Certified Public Accountants

Jacksonville, Florida

 

 

 

 

 

 

4

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN

Statements of Net Assets Available for Benefits

March 31, 2008 and 2007

 

 

 

 

 

2008

 

2007

 

Assets

 

 

 

 

 

 

 

Investments, at fair value

 

$

124,584,716

 

$

131,299,983

 

Receivables:

 

 

 

 

 

 

 

Employee contribution

 

 

952,122

 

 

4,024

 

Employer contribution

 

 

28,184

 

 

 

Total receivables

 

 

980,306

 

 

4,024

 

Total assets

 

 

125,565,022

 

 

131,304,007

 

Liabilities

 

 

 

 

 

 

 

Payables

 

 

707,754

 

 

681,674

 

Net assets available for benefits at fair value

 

$

124,857,268

 

$

130,622,333

 

Adjustment from fair value to contract value for

 

 

 

 

 

 

 

fully benefit-responsive investment contracts

 

 

332,363

 

 

125,813

 

Net assets available for benefits

 

$

125,189,631

 

$

130,748,146

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

5

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN

Statement of Changes in Net Assets Available for Benefits

Year ended March 31, 2008

 

 

 

 

 

2008

 

 

 

 

 

 

Additions to net assets available for benefits:

 

 

 

 

Investment Income:

 

 

 

 

Dividends and interest income

 

$

4,555,422

 

Total investment income

 

 

4,555,422

 

Contributions:

 

 

 

 

Participant

 

 

9,781,563

 

Employer

 

 

1,421,418

 

Rollovers from qualified plans

 

 

321,024

 

Total contributions

 

 

11,524,005

 

Total additions

 

 

16,079,427

 

Deductions from net assets available for benefits:

 

 

 

 

Benefits paid to participants

 

 

(6,932,704

)

Administrative expenses

 

 

(20,852

)

Net depreciation in fair value of investments

 

 

(14,684,386

)

Total deductions

 

 

(21,637,942

)

Net decrease

 

 

(5,558,515

)

Net assets available for benefits:

 

 

 

 

Beginning of year

 

 

130,748,146

 

End of year

 

$

125,189,631

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

6

 

(1)

Description of Plan

The following description of the PSS World Medical, Inc. Savings Plan (the Plan) provides only general information. Participants should refer to the plan document for a more complete description of the Plan’s provisions.

 

(a)

General

The Plan is a defined contribution retirement plan covering substantially all employees of PSS World Medical, Inc. and its subsidiaries (the Company or employer). The Plan was created under the provisions of Section 401(a) of the Internal Revenue Code (the IRC) and includes a qualified deferred arrangement, as described in Section 401(k) of the IRC, for the benefit of eligible employees of the Company. The Plan also has the features of an employee stock ownership plan (ESOP), whereby employee and employer contributions can be invested in PSS World Medical, Inc. common stock (the Company’s stock). The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, (ERISA), as amended.

 

(b)

Eligibility

Any employee of the Company is eligible to participate in the Plan upon completing 30 days of service. Plan entry dates are the first day of each month within the Plan year.

 

(c)

Contributions

The Plan is funded through voluntary employee salary deferrals and employer contributions. Participants can elect to defer up to 85% but not less than 1% of compensation, as defined by the Plan and as limited by requirements of the IRC. Participants who have attained age 50 before the close of the calendar year are eligible to make an additional elective deferral contribution. Participant elective contributions are invested by the Trustee in the investment options (mainly mutual funds and employer securities) as directed by the participant. The Plan also allows participants to make elective contributions from bonuses.

The Company may make the following types of contributions: (i) supplemental ESOP matching contributions, (ii) ESOP matching contributions, (iii) Non-ESOP matching contributions, (iv) ESOP employer contributions, and (v) Qualified Nonelective contributions.

Supplemental ESOP Matching Contributions

For the Plan year ended March 31, 2008, the Company made no Supplemental ESOP Matching Contributions.

ESOP Matching Contributions

For the Plan year ended March 31, 2008, the Company made no ESOP Matching Contributions.

Non-ESOP Matching Contributions

The Company’s board of directors may elect annually to make a discretionary contribution in the form of a non-ESOP matching contribution (contributions to be invested at the direction of the participant). Such contributions are allocated to participants based on the formula established by the board of directors. The board of directors also determines the percentage of participant elective contributions to be matched as well as the maximum amount of match to be contributed. A participant must make elective salary deferrals to be eligible for such matching contributions.

 

 

 

 

 

7

 

Non-ESOP Matching Contributions for each eligible participant are equal to the lesser of (i) 50% of a participant’s elective deferral amount up to 6% of a participant’s compensation for the Plan year or (ii) $1,250. This Non-ESOP Matching Contribution is subject to a six-year vesting schedule, as described in note 1(e), Vesting. The Non-ESOP Matching Contributions for the Plan year ended March 31, 2008 were $1,756,118.

ESOP Employer Contributions

There were no ESOP employer contributions for the Plan year ended March 31, 2008.

Qualified Nonelective Contributions

The Company’s board of directors may also elect annually to make qualified nonelective contributions. Such contributions may be allocated to a limited number of nonhighly compensated employees and are only made to eliminate potential discrimination with respect to participant elective contributions or employer matching contributions that would otherwise favor highly compensated employees. There were no qualified nonelective contributions for the Plan year ended March 31, 2008.

 

(d)

Vesting

Participants are immediately vested in their contributions. Participants are vested in the Company’s ESOP matching contributions, Non-ESOP matching contributions, ESOP employer contributions, and earnings thereon based on years of continuous service, as defined in the Plan, according to the following schedule:

 

 

Less than two years of service

0%

Two years but less than three years

20%

Three years but less than four years

40%

Four years but less than five years

60%

Five years but less than six years

80%

Six years or more

100%

 

 

 

In the event of total and permanent disability or death, a participant shall become 100% vested in the participant’s account balance.

 

(e)

Forfeited Accounts

Nonvested portions of the Company’s discretionary contributions are forfeited as of a participant’s termination date and are used to reduce future Company matching contributions. During the Plan year ended March 31, 2008, forfeitures of nonvested accounts totaled $90,102. At March 31, 2008 and March 31, 2007, forfeited, nonvested accounts of $59,182 and $303,870, respectively, were reflected in the accompanying statements of net assets available for benefits.

 

(f)

Benefits Paid to Participants

Upon retirement, death, disability, or other severance of employment, a participant or his/her beneficiary may elect to receive an amount equal to the value of the participant’s vested interest in the participant’s account. Balances in participant accounts are paid in a single lump sum. On December 26, 2003, the Plan was amended to comply with final regulations issued under Code Section 401(a)(9) regarding required minimum distributions.

 

 

 

 

 

8

 

Participants who have an account balance in the Company’s stock fund will have their account balances distributed in shares of the Company’s stock (with fractional shares paid in cash) or cash as elected by the participant with payment to the participant at their direction. On March 28, 2005, the Plan was amended to address federally mandated automatic rollovers, where certain distributions may be rolled over to an Individual Retirement Plan. On April 1, 2006, the Plan was amended to add two new reasons for receiving a hardship withdrawal and a restriction was placed on making bottom-up qualified nonelective contributions.

 

(g)

Participant Loans

The Plan does not permit participant loans.

 

(h)

Participant Accounts

Each participant’s account is credited with the participant’s contributions, allocations of the Company’s contribution, and an allocation of Plan earnings. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s vested account.

 

(i)

Voting Rights

Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account and is notified by the Transfer Agent of the Company prior to the time that such rights are to be exercised. The Trustee will vote any allocated shares according to the instructions given by a participant. If no instructions are given to the Trustee by a participant, the Trustee will vote any allocated shares on behalf of the collective best interest of plan participants and beneficiaries.

 

(2)

Summary of Significant Accounting Policies

 

(a)

Basis of Accounting

The accompanying financial statements have been prepared on the accrual basis of accounting.

 

(b)

Use of Estimates

The preparation of the financial statements in conformity with U.S. generally accepted accounting principals requires the Plan’s management to use estimates and assumptions that affect the accompanying financial statements and disclosures. Actual results could differ from these estimates.

In December 2005, the Financial Accounting Standards Board (FASB) issued FASB Staff Position AAG INV-1 and SOP 94-4-1, Reporting of Fully Benefit-Responsive Investment Contracts Held by Certain Investment Companies Subject to the AICPA Investment Company Guide and Defined-Contribution Health and Welfare and Pension Plans (“the FSP”). The FSP defines the circumstances in which an investment contract is considered fully benefit responsive and provides certain reporting and disclosure requirements for fully benefit responsive investment contracts in defined contribution health and welfare and pension plans. The financial statement presentation and disclosure provisions of the FSP are effective for financial statements issued for annual periods ending after December 15, 2006 and are required to be applied retroactively to all prior periods presented for comparative purposes. The Plan has adopted the provisions of the FSP at March 31, 2007.

 

 

 

 

 

9

 

As required by the FSP, investments in the accompanying Statements of Net Assets Available for Benefits include fully benefit responsive investment contracts recognized at fair value. However, contract value is the relevant measurement attribute for that portion of net assets available for benefits of a defined-contribution plan attributable to fully benefit-responsive investment contracts because contract value is the amount participants would receive if they were to initiate permitted transactions under the terms of the plan. The plan invests in contracts through a collective trust. Contract value for this collective trust is based on the net asset value of the fund as reported by the investment advisor. AICPA Statement of Position 94-4-1, Reporting of Investment Contracts Held by Health and Welfare Benefit Plans and Defined Contribution Pension Plans, as amended, requires fully benefit responsive investment contracts to be reported at fair value in the Plan’s Statement of Net Assets Available for Benefits with a corresponding adjustment to reflect these investments at contract value. Adoption of the FSP had no effect on the Statement of Changes in Net Assets Available for Benefits.

 

(c)

Income Recognition

Interest income is recorded as earned on the accrual basis of accounting. Dividend income is recorded on the ex-dividend date. Net appreciation in fair value of investments is allocated on a daily basis to participant accounts. Purchases and sales of investments are recorded on a trade date basis.

 

(d)

Investment Valuation

Investments in mutual funds are stated at fair value, which is based on published market quotations on national exchanges. Investments in common collective trusts are stated at the fair value of the underlying investments as based on information using the audited financial statements of the collective trust and changes in such amounts through the Plan’s year end. Money market funds are valued at cost, which approximates fair value. The Company’s common stock as of March 31, 2008 is valued at a unit value determined by the amount of shares of stock and cash held within the unitized stock fund.

 

(e)

Payment of Benefits

Benefits are recorded when paid.

 

(f)

Net Depreciation in Fair Value of Investments

Net realized gains (losses) from the sales of investments and the changes in the unrealized appreciation (depreciation) on investments held are recorded in the accompanying statement of changes in net assets available for benefits as net depreciation in fair value of investments.

 

(g)

Administrative Expenses

Administrative expenses reflected in the statement of changes in net assets available for benefits of $20,852 represent distribution fees paid by participants. All other Plan expenses were paid by the Company for the year ended March 31, 2008.

 

(h)

Recent Accounting Pronouncements

In September 2006, the FASB issued Statement on Financial Accounting Standards No. 157 (“SFAS 157”), Fair Value Measurements. SFAS 157 establishes a single authoritative definition of fair value, sets out a framework for measuring fair value and requires additional disclosures about fair value measurement. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. The Company does not believe the adoption of SFAS 157 will have a material impact on the financial statements.

 

 

 

 

 

10

 

(3)

Investments

All investment elections are participant-directed funds. The following presents investments that represent 5% or more of the Plan’s net assets as of March 31, 2008 and 2007:

Description of Asset

2008

2008

2007

2007

 

Units

Value

Units

Value

PSS World Medical Inc. Common stock

1,925,880

$28,885,217

2,056,404   

$39,174,817   

Janus Mid Cap Value Fund

545,076

11,686,438

483,439   

11,955,417   

ABN AMRO Income Plus Fund*

1,683,176

10,923,307

1,940,970   

12,044,689   

T Rowe Price Growth Stock Fund

370,168

10,757,068

340,342   

10,690,140   

Principal Global Investors S&P 500 Index

1,094,427

10,243,838

920,899   

9,356,328   

American EuroPacific Growth Fund

202,608

9,488,120

159,569   

7,646,563   

PIMCO Total Return Fund

792,795

8,649,397

652,199

6,802,432   

William Blair Small Cap Growth Fund

385,243

7,654,785

379,893   

9,850,624    

Oppenheimer Global Fund

83,745

5,410,780

79,542   

5,853,487   

 

 

 

 

 

* Amounts for the ABN AMRO Income Plus Fund are stated at contract value

During the year ended March 31, 2008 the Plan’s investments (including gains and losses on investments bought and sold, as well as held during the year) depreciated in value as follows:

 

 

 

 

 

PSS World Medical, Inc. common stock

 

$

( 7,655,276

)

Mutual funds

 

 

(6,786,186

)

Common collective trusts

 

 

(242,924

)

Net depreciation in fair value of investments

 

$

(14,684,386

)

 

 

 

 

 

(4)

Tax Status

The Internal Revenue Service has determined and informed the Company by a letter dated July 21, 2003, that the Plan and related trust are designed in accordance with applicable sections of the IRC. Although the Plan has been amended since receiving the determination letter, the Plan administrator believes that the Plan continues to be designed and is currently being operated in compliance with the applicable requirements of the IRC and the Plan document.

(5)

Plan Termination

Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of plan termination, participants would become fully vested in their employer contributions.

(6)

Related Party Transactions

At March 31, 2008 and 2007, the Plan owned 1,696,507 and 1,845,554 shares of the Company’s common stock, respectively, which represents approximately 2.7% and 2.7% of the outstanding common stock of the Company, respectively.

At March 31, 2008 payables to participants to satisfy the Actual Deferral Percentage Test totaled $683,458, and payables to Principal Financial Group representing pending trades totaled $24,296.

(7)

Risk and Uncertainties

The Plan invests in various investment securities including the Company’s common stock (approximately 23% of net assets available for benefits at March 31, 2008), as described in note 3. Investment securities are exposed to various risks such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the statements of net assets available for benefits.

 

11

 

(8)

Reconciliation of Financial Statements to Form 5500

The following is a reconciliation of net assets available for benefits per the financial statements at March 31, 2008 and 2007 to Form 5500:

 

 

 

2008

 

2007

 

Net assets available for benefits per the financial statements

 

$

125,189,631

 

$

130,748,146

 

Benefits allocated to participants

 

 

707,754

 

 

681,674

 

Adjustment to fair value from contract value for investment

 

 

 

 

 

 

 

relating to fully benefit-responsive investment contracts

 

 

(332,363

)

 

(125,813

)

Net assets available for benefit per Form 5500

 

$

125,565,022

 

$

131,304,007

 

 

The following is a reconciliation of the change in net assets available for benefits per the financial statements at March 31, 2008 to Form 5500:

 

 

 

2008

 

Change in net assets available for benefits per the financial statements

 

$

(5,558,515

)

Benefits allocated to participants

 

 

707,754

 

Prior year benefits allocated to participants

 

 

(681,674

)

Adjustment to fair value from contract value for investment

 

 

 

 

relating to fully benefit-responsive investment contracts

 

 

(332,363

)

Prior year adjustment to fair value from contract value for investment

 

 

 

 

relating to fully benefit-responsive investment contracts

 

 

125,813

 

Net income per Form 5500

 

$

(5,738,985

)

 

(9)

Untimely Remittance

At March 31, 2007, the Company had not remitted $4,650 in participant contributions within the prescribed time frames required by DOL Regulation 2510.3-102. The Company filed Form 5330 with the IRS and paid the required excise tax on the transaction. In addition, on April 6, 2007 participant accounts were credited with the amount of investment income which would have been earned had the participant contribution been remitted on a timely basis.

 

 

 

 

 

 

 

12

 

Schedule H, Line 4a – Schedule of Delinquent Participant Contributions March 31, 2008

Identity of party involved

Relationship to plan employer or other party-in-interest

Lost Interest

Principal Value on line 4(a)

PSS World Medical, Inc.

Plan sponsor

$ 101

$ 4,650

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying independent registered public accounting firm’s report.

 

 

 

 

 

 

 

 

 

13

 

Schedule H, Line 4i – Schedule of Assets (Held at End of Year) March 31, 2008

 

Identity of party involved

 

Description of investment

Current Value

*

PSS World Medical, Inc.

 

PSS World Medical, Inc. common stock 1,696,507

 

 

 

 

underlying shares

$28,885,217   

 

Janus Capital Group

 

Janus Mid Cap Value Fund

9,820,859   

 

T Rowe Price

 

T Rowe Price Growth Stock Fund

8,539,622   

 

William Blair & Company

 

William Blair Small Cap Growth Fund

7,292,248   

 

ABN AMRO Asset Management

 

ABN AMRO Income Plus Fund

7,187,823   

 

American Funds Service Company

 

American EuroPacific Growth Fund

6,749,933   

 

Pacific Investment Management Company

 

PIMCO Total Return Fund

6,033,848   

 

 

 

PIMCO Real Return Admin Fund

1,124,178   

*

Principal Financial Group

 

Principal Global Investors S&P 500 Index

5,461,934   

 

Oppenheimer Funds

 

Oppenheimer Global Fund

5,410,780   

 

Van Kampen Investments

 

Van Kampen Growth & Income Fund

3,361,657   

 

Royce & Associates

 

Royce Pennsylvania Mutual Fund

3,227,120   

 

Goldman Sachs Asset Management

 

Goldman Sachs Growth Opportunities Fund

2,235,413   

 

Alliance Capital Management

 

Alliance Growth & Income Fund

1,223,110   

 

 

 

 

 

*

Principal Financial Group

 

PSS World Medical, Inc., Moderate Portfolio, 1,968,334 units

 

 

 

*

Principal Global Investors S&P 500 Index

2,509,439   

 

 

 

ABN AMRO Income Plus Fund

2,450,607   

 

 

 

PIMCO Real Return Admin Fund

1,886,503   

 

 

 

PIMCO Total Return Fund

1,863,121   

 

 

 

Alliance Growth & Income Fund

1,563,277   

 

 

 

American EuroPacific Growth Fund

1,411,403   

 

 

 

Van Kampen Growth & Income Fund

1,071,081   

 

 

 

T Rowe Price Growth Stock Fund

1,070,595   

 

 

 

Janus Mid Cap Value Fund

994,475   

 

 

 

Goldman Sachs Growth Opportunities Fund

663,497   

 

 

 

Royce Pennsylvania Mutual Fund

505,776   

 

 

 

William Blair Small Cap Growth Fund

153,882   

 

 

 

 

16,143,656   

*

Principal Financial Group

 

PSS World Medical, Inc., Moderate Aggressive Portfolio, 666,083 units

 

 

 

*

Principal Global Investors S&P 500 Index

1,088,772   

 

 

 

Alliance Growth & Income Fund

682,404   

 

 

 

American EuroPacific Growth Fund

615,307   

 

 

 

T Rowe Price Growth Stock Fund

550,534   

 

 

 

Van Kampen Growth & Income Fund

541,393   

 

 

 

ABN AMRO Income Plus Fund

415,580   

 

 

 

Janus Mid Cap Value Fund

382,979   

 

 

 

PIMCO Total Return Fund

324,473   

 

 

 

PIMCO Real Return Admin Fund

320,203   

 

 

 

Goldman Sachs Growth Opportunities Fund

281,611   

 

 

 

Royce Pennsylvania Mutual Fund

166,290   

 

 

 

William Blair Small Cap Growth Fund

110,033   

 

 

 

 

5,479,579   

*

Principal Financial Group

 

PSS World Medical, Inc., Aggressive Portfolio, 508,514 units

 

 

 

*

Principal Global Investors S&P 500 Index

1,041,848   

 

 

 

Alliance Growth & Income Fund

716,571   

 

 

 

American EuroPacific Growth Fund

630,244   

 

 

 

Van Kampen Growth & Income Fund

526,729   

 

 

 

T Rowe Price Growth Stock Fund

526,233   

 

 

 

Janus Mid Cap Value Fund

428,032   

 

 

 

Goldman Sachs Growth Opportunities Fund

285,272   

 

 

 

Royce Pennsylvania Mutual Fund

193,412   

 

 

 

William Blair Small Cap Growth Fund

88,167   

 

 

 

 

4,436,508   

 

 

14

 

 

 

*

Principal Financial Group

 

PSS World Medical, Inc., Moderate Conservative Portfolio, 141,739 units

 

 

 

 

ABN AMRO Income Plus Fund

241,512   

 

 

 

PIMCO Total Return Fund

196,014   

 

 

 

PIMCO Real Return Admin Fund

175,568   

 

 

*

Principal Global Investors S&P 500 Index

105,021   

 

 

 

Alliance Growth & Income Fund

74,401   

 

 

 

American EuroPacific Growth Fund

62,761   

 

 

 

Van Kampen Growth & Income Fund

52,270   

 

 

 

T Rowe Price Growth Stock Fund

51,713   

 

 

 

Janus Mid Cap Value Fund

41,633   

 

 

 

Goldman Sachs Growth Opportunities Fund

21,640   

 

 

 

Royce Pennsylvania Mutual Fund

21,225   

 

 

 

William Blair Small Cap Growth Fund

10,455   

 

 

 

 

1,054,213   

*

Principal Financial Group

 

PSS World Medical, Inc., Conservative Portfolio, 135,735 units

 

 

 

 

ABN AMRO Income Plus Fund

295,422   

 

 

 

PIMCO Real Return Admin Fund

232,906   

 

 

 

PIMCO Total Return Fund

231,941   

 

 

*

Principal Global Investors S&P 500 Index

36,824   

 

 

 

Alliance Growth & Income Fund

27,759   

 

 

 

American EuroPacific Growth Fund

18,472   

 

 

 

Janus Mid Cap Value Fund

18,460   

 

 

 

T Rowe Price Growth Stock Fund

18,371   

 

 

 

Goldman Sachs Growth Opportunities Fund

18,337   

 

 

 

Van Kampen Growth & Income Fund

9,317   

 

 

 

Royce Pennsylvania Mutual Fund

9,209   

 

 

 

 

917,018   

 

 

 

 

$ 124,584,716   

 

* Party-in-interest

 

 

 

 

 

 

 

 

 

See accompanying independent registered public accounting firm’s report.

 

15

 

SIGNATURES

 

The Plan. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned, hereunto duly authorized.

Date: September 18, 2008

 

 

 

 

PSS WORLD MEDICAL, INC. SAVINGS PLAN

 

 

 

 

 

By:

PSS World Medical, Inc., as Plan Administrator

 

 

 

 

 

By:


/s/ David M. Bronson

 

 

 

Executive Vice President and Chief Financial Officer

(Duly Authorized Officer and Principal Financial and Accounting Officer

 

 

 

 

 

 

 

 

 

16

 

 

EXHIBIT INDEX

 

Exhibit Number

 

 

 

23

Consent of Independent Registered Public Accounting Firm

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17